CNBX Pharmaceuticals Inc. Common Stock Shares Outstanding

Quick Answer

CNBX Pharmaceuticals Inc. reported Common Stock Shares Outstanding of 553.96 million shares for the year ending 2025.

  • CNBX Pharmaceuticals Inc. showed an increase of +1,680.6% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from CNBX Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on December 1, 2025.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2013 to 2025), CNBX Pharmaceuticals Inc.'s Common Stock Shares Outstanding has grown by 40,620.4%.
  • Historical annual values: Fiscal year 2025: 553.96 million shares | Fiscal year 2024: 31.11 million shares | Fiscal year 2023: 22.61 million shares | Fiscal year 2022: 1.24 million shares | Fiscal year 2021: 148.66 million shares | Fiscal year 2020: 135.08 million shares | Fiscal year 2019: 134.50 million shares | Fiscal year 2018: 121.58 million shares | Fiscal year 2017: 119.54 million shares | Fiscal year 2016: 107.22 million shares | Fiscal year 2015: 101.50 million shares | Fiscal year 2014: 100.25 million shares | Fiscal year 2013: 1.36 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: